[PHARMA] YoY Annualized Quarter Result on 30-Sep-2017 [#3]

Announcement Date
15-Nov-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Sep-2017 [#3]
Profit Trend
QoQ- -24.94%
YoY- -31.04%
Quarter Report
View:
Show?
Annualized Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 2,787,317 2,806,462 2,384,416 2,281,018 2,141,608 2,012,216 1,994,440 5.73%
PBT 65,732 62,145 77,706 70,930 90,597 118,673 116,968 -9.15%
Tax -21,310 -23,097 -26,160 -27,065 -28,252 -27,282 -40,162 -10.01%
NP 44,421 39,048 51,546 43,865 62,345 91,390 76,805 -8.71%
-
NP to SH 45,093 39,172 50,708 42,697 61,913 90,642 76,196 -8.36%
-
Tax Rate 32.42% 37.17% 33.67% 38.16% 31.18% 22.99% 34.34% -
Total Cost 2,742,896 2,767,414 2,332,869 2,237,153 2,079,262 1,920,825 1,917,634 6.14%
-
Net Worth 345,040 516,387 522,618 531,892 530,907 534,070 507,513 -6.22%
Dividend
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Div 34,852 29,557 48,535 44,973 44,889 79,389 55,239 -7.38%
Div Payout % 77.29% 75.46% 95.71% 105.33% 72.50% 87.59% 72.50% -
Equity
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Net Worth 345,040 516,387 522,618 531,892 530,907 534,070 507,513 -6.22%
NOSH 261,705 261,229 260,505 259,821 258,979 258,880 258,935 0.17%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 1.59% 1.39% 2.16% 1.92% 2.91% 4.54% 3.85% -
ROE 13.07% 7.59% 9.70% 8.03% 11.66% 16.97% 15.01% -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
RPS 1,066.33 1,076.09 917.05 879.14 826.94 777.28 770.25 5.56%
EPS 17.25 15.01 19.51 16.45 23.91 35.01 29.43 -8.51%
DPS 13.33 11.33 18.67 17.33 17.33 30.67 21.33 -7.52%
NAPS 1.32 1.98 2.01 2.05 2.05 2.063 1.96 -6.37%
Adjusted Per Share Value based on latest NOSH - 259,821
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
RPS 193.40 194.73 165.44 158.27 148.60 139.62 138.38 5.73%
EPS 3.13 2.72 3.52 2.96 4.30 6.29 5.29 -8.36%
DPS 2.42 2.05 3.37 3.12 3.11 5.51 3.83 -7.35%
NAPS 0.2394 0.3583 0.3626 0.3691 0.3684 0.3706 0.3521 -6.22%
Price Multiplier on Financial Quarter End Date
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Date 30/09/20 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 -
Price 4.32 2.44 2.89 4.14 5.58 6.50 4.63 -
P/RPS 0.41 0.23 0.32 0.47 0.67 0.84 0.60 -6.14%
P/EPS 25.04 16.25 14.82 25.16 23.34 18.56 15.73 8.04%
EY 3.99 6.16 6.75 3.97 4.28 5.39 6.36 -7.46%
DY 3.09 4.64 6.46 4.19 3.11 4.72 4.61 -6.44%
P/NAPS 3.27 1.23 1.44 2.02 2.72 3.15 2.36 5.58%
Price Multiplier on Announcement Date
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Date 19/11/20 20/11/19 19/11/18 15/11/17 21/11/16 26/11/15 21/11/14 -
Price 5.72 2.21 3.09 3.82 5.70 6.50 4.45 -
P/RPS 0.54 0.21 0.34 0.43 0.69 0.84 0.58 -1.18%
P/EPS 33.16 14.71 15.84 23.21 23.84 18.56 15.12 13.97%
EY 3.02 6.80 6.31 4.31 4.19 5.39 6.61 -12.22%
DY 2.33 5.13 6.04 4.54 3.04 4.72 4.79 -11.30%
P/NAPS 4.33 1.12 1.54 1.86 2.78 3.15 2.27 11.35%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment